Residual paralysis in the recovery period.
D006801:Humans; D009388:Neostigmine / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*; D009469:Neuromuscular Junction / Q000502:physiology; D010243:Paralysis / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D011183:Postoperative Complications; D011184:Postoperative Period
D009466:Neuromuscular Blocking Agents; D009388:Neostigmine